论文部分内容阅读
目的探讨加味理中汤用于结直肠癌化疗致外周神经病变治疗的临床效果。方法采用随机分组的方式将2015年1月—2017年6月该院因患有结直肠癌而来该院进行西医化疗的患者100例分为观察组和对照组,每组50例,其中给予对照组单纯西药化疗,给予观察组在对照组基础上加味理中汤中药治疗,将两组患者的外周神经病变发生率以及轻重程度进行比较分析。结果观察组外周神经病变Ⅰ度9例、Ⅱ度5例,外周神经病变发生率为28%,对照组外周神经病变Ⅰ度23例、Ⅱ度10例、Ⅲ度2例,外周神经病变发生率为70%,观察组外周神经病变发生率与对照组相比显著较低,差异有统计学意义(P<0.05)。结论针对结直肠癌患者在西医化疗基础上采用加味理中汤中医药治疗,能够减少外周神经病变的发生率,降低发生强度,在临床上推广普及很有价值。
Objective To investigate the clinical effect of Jiaweili Zhongtang in the treatment of peripheral neuropathy caused by chemotherapy of colorectal cancer. Methods A randomized group of 100 patients who were hospitalized with chemotherapy for colorectal cancer in our hospital from January 2015 to June 2017 were divided into observation group and control group with 50 cases in each group The control group was treated with western medicine only, and the observation group was given Jiaweiliizhong decoction on the basis of the control group. The incidence and severity of peripheral neuropathy in the two groups were compared. Results Peripheral neuropathy in observation group had 9 cases of degree Ⅰ, 5 cases of degree Ⅱ and 28% of peripheral neuropathy. The control group had 23 cases of degree Ⅰ of peripheral neuropathy, 10 cases of degree Ⅱ and 2 cases of degree Ⅲ. The incidence of peripheral neuropathy Was 70%. The incidence of peripheral neuropathy in the observation group was significantly lower than that in the control group (P <0.05). Conclusion For patients with colorectal cancer based on Western medicine based on the use of Jiaweili Zhong Tang Chinese medicine treatment can reduce the incidence of peripheral neuropathy and reduce the intensity of occurrence in the clinical popularization of great value.